UROY revenueQ1 2027$50.97M
- Quarter YoY
- +110.2%
- FY YoY
- 17x
UROY revenue was $50.97M in fiscal Q1 2027 (ended Jul 31, 2026), up 110.2% from a year earlier. For the full fiscal 2026 it was $186.81M, up about 17-fold from fiscal 2025.
For fiscal 2026 (ended Apr 30, 2026), Uranium Royalty Corp. reported $186.81M of revenue and $40.25M of net income.
UROY revenue was $50.97M in fiscal Q1 2027 (ended Jul 31, 2026), up 110.2% from a year earlier. For the full fiscal 2026 it was $186.81M, up about 17-fold from fiscal 2025.
UROY net income was $16.25M in fiscal Q1 2027 (ended Jul 31, 2026), up about 16-fold from a year earlier. For the full fiscal 2026 it was $40.25M, compared with -$4.51M in fiscal 2025.
UROY diluted EPS was $0.10 in fiscal Q1 2027 (ended Jul 31, 2026), up 900.0% from a year earlier. For the full fiscal 2026 it was $0.29, compared with -$0.04 in fiscal 2025.
| Line item | Apr 30, 2026 | Apr 30, 2025 | Apr 30, 2024 |
|---|---|---|---|
| Revenue | $186.81M | $11.21M | $31.20M |
| Selling, general and admin | $5.29M | $4.80M | $4.97M |
| Operating income | $48.32M | -$3.44M | $5.09M |
| Interest expense | $0 | $303.0K | $0 |
| Pre-tax income | $54.64M | -$5.64M | $16.90M |
| Income tax | $14.39M | -$1.14M | $3.19M |
| Net income | $40.25M | -$4.51M | $13.71M |
| EPS, basic | $0.29 | -$0.04 | $0.13 |
| EPS, diluted | $0.29 | -$0.04 | $0.12 |
| Diluted shares | 139.4M | 126.8M | 115.2M |
| Line item | Apr 30, 2026 | Apr 30, 2025 | Apr 30, 2024 |
|---|---|---|---|
| Cash and equivalents | $282.04M | $9.45M | $15.39M |
| Receivables | $59.0K | $31.0K | - |
| Inventory | $34.33M | $157.62M | $135.79M |
| Current assets | $329.30M | $172.59M | - |
| Total assets | $373.32M | $216.12M | - |
| Current liabilities | $55.48M | $739.0K | - |
| Short-term debt | $0 | - | - |
| Long-term debt | $0 | - | - |
| Total debt | $0 | - | - |
| Total liabilities | $60.55M | $1.02M | - |
| Shareholders' equity | $312.77M | $215.10M | $200.41M |
| Line item | Apr 30, 2026 | Apr 30, 2025 | Apr 30, 2024 |
|---|---|---|---|
| Operating cash flow | $178.46M | -$15.06M | -$76.43M |
| Investing cash flow | $798.0K | -$8.59M | $32.49M |
| Financing cash flow | $93.70M | $18.45M | $49.24M |
| Stock-based compensation | $746.0K | $561.0K | $547.0K |
| Depreciation and amortization | $111.0K | $47.0K | $0 |
| Line item | Jul 31, 2026 | Jul 31, 2025 |
|---|---|---|
| Revenue | $50.97M | $24.25M |
| Selling, general and admin | $964.0K | $1.33M |
| Operating income | $16.41M | $2.25M |
| Interest expense | $499.0K | $0 |
| Pre-tax income | $23.09M | $1.40M |
| Income tax | $6.83M | $379.0K |
| Net income | $16.25M | $1.02M |
| EPS, basic | $0.10 | $0.01 |
| EPS, diluted | $0.10 | $0.01 |
| Diluted shares | 157.3M | 133.7M |
| Line item | Jul 31, 2026 | Jul 31, 2025 |
|---|---|---|
| Cash and equivalents | $54.10M | $6.56M |
| Receivables | $4.20M | - |
| Inventory | $220.0K | - |
| Current assets | $120.79M | - |
| Total assets | $1.91B | - |
| Current liabilities | $138.04M | - |
| Short-term debt | $17.10M | - |
| Long-term debt | $535.66M | - |
| Total debt | $552.76M | - |
| Total liabilities | $819.51M | - |
| Shareholders' equity | $961.54M | $215.36M |
| Line item | Jul 31, 2026 | Jul 31, 2025 |
|---|---|---|
| Operating cash flow | $52.97M | $23.41M |
| Investing cash flow | -$265.53M | -$25.76M |
| Financing cash flow | $40.26M | $4.0K |
| Stock-based compensation | $78.0K | $62.0K |
| Depreciation and amortization | $188.0K | $31.0K |
Source: XBRL data Uranium Royalty Corp. files with the SEC, latest filing dated Sep 14, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| UROY | $186.81M | +1566.0% | $40.25M | 21.5% | $1.15B |
| MS | $80.16B | +16.2% | $20.45B | 25.5% | $284.96B |
| GS | $69.70B | +18.7% | $22.17B | 31.8% | $249.73B |
| BLK | $28.54B | +24.7% | $6.91B | 24.2% | $182.05B |
| SCHW | $27.06B | +18.1% | $10.64B | 39.3% | $158.22B |
| CME | $6.97B | +9.0% | $4.43B | 63.5% | $109.49B |
| ICE | $14.05B | +12.1% | $4.16B | 29.6% | $96.27B |
| HOOD | $5.08B | +20.9% | $1.98B | 39.0% | $72.86B |
| NDAQ | $9.15B | +11.5% | $2.08B | 22.8% | $59.44B |